COSYNE THERAPEUTICS
Live / Applied — Statement of use — non-final action mailed (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 25 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97427191
- Mark type
- Design + words
- Filed
- 25 May 2022
- Published for opposition
- 09 May 2023
- Attorney of record
- Nigamnarayan Acharya
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development purposes
Owner
- CoSyne Therapeutics Limited, London, GB
- CoSyne Therapeutics Limited, London, GB
Prosecution history
- 07 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Jan 2026 — NON-FINAL ACTION E-MAILED
- 07 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 07 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2025 — USE AMENDMENT FILED
- 22 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2025 — SOU EXTENSION 4 GRANTED
- 05 Jul 2025 — SOU EXTENSION 4 FILED
- 15 Oct 2025 — SOU EXTENSION 3 GRANTED
- 05 Jan 2025 — SOU EXTENSION 3 FILED
- 14 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jul 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 18 Jul 2025 — NOTICE OF REVIVAL - E-MAILED